A10B (Blood glucose lowering drugs, excl. insulins)
GPTKB entity
Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:ATCCode |
A10B
|
| gptkbp:excludes |
Insulins
|
| gptkbp:includes |
A10BD (Combinations of oral blood glucose lowering drugs)
A10BA (Biguanides) A10BB (Sulfonylureas) A10BC (Sulfonamides, urea derivatives) A10BF (Alpha glucosidase inhibitors) A10BG (Thiazolidinediones) A10BH (Dipeptidyl peptidase 4 (DPP-4) inhibitors) A10BJ (Glucagon-like peptide-1 (GLP-1) analogues) A10BK (Sodium-glucose co-transporter 2 (SGLT2) inhibitors) |
| gptkbp:partOf |
ATC code A10 (Drugs used in diabetes)
|
| gptkbp:regulates |
gptkb:WHO_ATC_classification_system
|
| gptkbp:usedFor |
gptkb:Type_2_diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:A10BJ06
gptkb:A10BX03 |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
A10B (Blood glucose lowering drugs, excl. insulins)
|